Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors von I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko

Volltext

TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia von N. I. Bilous, I. V. Abramenko, A. A. Chumak, I. S. Dyagil, Z. V. Martina

Volltext

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy von I. O. Sviezhentseva, T. P. Perekhrestenko, D. I. Bilko, A. I. Gordienko, M. V. Diachenko, I. S. Dyagil

Volltext